Search by Drug Name or NDC

    NDC 49035-0819-40 equate daytime vapor ice cold and flu 650; 20; 400; 10 mg/30mL; mg/30mL; mg/30mL; mg/30mL Details

    equate daytime vapor ice cold and flu 650; 20; 400; 10 mg/30mL; mg/30mL; mg/30mL; mg/30mL

    equate daytime vapor ice cold and flu is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Wal-Mart Stores Inc. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 49035-0819
    Product ID 49035-819_f0cb138e-2a6f-4c75-a10f-214564487963
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name equate daytime vapor ice cold and flu
    Proprietary Name Suffix n/a
    Non-Proprietary Name acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 20; 400; 10
    Active Ingredient Units mg/30mL; mg/30mL; mg/30mL; mg/30mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Wal-Mart Stores Inc
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 49035-0819-40 (49035081940)

    NDC Package Code 49035-819-40
    Billing NDC 49035081940
    Package 355 mL in 1 BOTTLE (49035-819-40)
    Marketing Start Date 2019-10-03
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 0efe535b-63fb-4d37-853c-4592fc8ee36b Details

    Revised: 10/2022